Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.

scientific article published on September 2010

Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1071/SH10022
P698PubMed publication ID20719230

P50authorEduardo L. FrancoQ39669535
Salaheddin M. MahmudQ42242293
François CoutléeQ91076500
Alex S FerenczyQ117265509
P2093author name stringJoseph Tota
P433issue3
P921main subjectcervix uterine cancerQ160105
P304page(s)376-382
P577publication date2010-09-01
P1433published inSexual HealthQ15760399
P1476titlePromising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
P478volume7

Reverse relations

cites work (P2860)
Q34220578Adolescent and young adult HPV vaccination in Australia: achievements and challenges.
Q40432574Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference
Q38161335Cumulative Epigenetic Abnormalities in Host Genes with Viral and Microbial Infection during Initiation and Progression of Malignant Lymphoma/Leukemia
Q44222617Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
Q37941160Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies
Q35319696Feasibility of self-sampling and human papillomavirus testing for cervical cancer screening in First Nation women from Northwest Ontario, Canada: a pilot study
Q41439564Human papillomavirus (HPV) types 16 and 18 in liquid-based cervical cytology samples
Q38255277Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs
Q33734307Intent to participate in future cervical cancer screenings is lower when satisfaction with the decision to be vaccinated is neutral
Q40299388Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm
Q35585448Oncogenic HPV Types Infection in Adolescents and University Women from North Portugal: From Self-Sampling to Cancer Prevention
Q40522685Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era.
Q36558983Reproducibility of linear array for human papillomavirus genotyping
Q37719631The road ahead for cervical cancer prevention and control
Q39011307The significantly lower risk of cervical cancer at and after the recommended age to begin and end screening compared to breast and colorectal cancer
Q36423616Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010

Search more.